The yeast strain (Saccharomyces cerevisiae) MTCC 3157
was selected for combinatorial biosynthesis of plant sesquiterpene amorpha-4,11-diene.
Our main objective was to overproduce amorpha 4-11-diene, which is a key precursor molecule of
artemisinin (antimalarial drug) produced naturally in plant Artemisia annua through
mevalonate pathway. Farnesyl diphosphate (FPP) is a common intermediate metabolite of a variety
of compounds in the mevalonate pathway of yeast and leads to the production of ergosterols,
dolichol and ubiquinone, and so forth. In our studies, FPP converted to amorphadiene (AD) by
expressing heterologous amorphadiene synthase (ADS) in yeast. First,
ERG9 (squalane synthase) promoter of yeast was replaced with repressible
methionine (MET3) promoter by using bipartite gene fusion method. Further to overcome the loss of the
intermediate FPP through competitive pathways in yeast, fusion protein technology was adopted
and farnesyldiphosphate synthase (FPPS) of yeast has been coupled with amorphadiene
synthase (ADS) of plant origin (Artemisia annua L.) where amorphadiene
production was improved by 2-fold (11.2 mg/L) and 4-fold (25.02 mg/L) in yeast strains
YCF-002 and YCF-005 compared with control strain YCF-AD (5.5 mg/L), respectively.